These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 19560535

  • 1. Fatigue in primary Sjögren's syndrome--a link to sickness behaviour in animals?
    Harboe E, Tjensvoll AB, Vefring HK, Gøransson LG, Kvaløy JT, Omdal R.
    Brain Behav Immun; 2009 Nov; 23(8):1104-8. PubMed ID: 19560535
    [Abstract] [Full Text] [Related]

  • 2. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
    Katsarou Z, Bostantjopoulou S, Hatzizisi O, Giza E, Soler-Cardona A, Kyriazis G.
    Rev Neurol; 2009 Nov; 45(12):725-8. PubMed ID: 18075986
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren's syndrome.
    Bårdsen K, Brede C, Kvivik I, Kvaløy JT, Jonsdottir K, Tjensvoll AB, Ruoff P, Omdal R.
    J Neuroinflammation; 2019 May 17; 16(1):102. PubMed ID: 31101054
    [Abstract] [Full Text] [Related]

  • 4. Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines.
    Baturone R, Soto MJ, Márquez M, Macías I, de Oca MM, Medina F, Chozas N, García-Pérez S, Girón-González JA.
    Scand J Rheumatol; 2009 May 17; 38(5):386-9. PubMed ID: 19575332
    [Abstract] [Full Text] [Related]

  • 5. Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome.
    Hartkamp A, Geenen R, Bijl M, Kruize AA, Godaert GL, Derksen RH.
    Ann Rheum Dis; 2004 Oct 17; 63(10):1335-7. PubMed ID: 15361396
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.
    Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P.
    Ann Rheum Dis; 2008 Nov 17; 67(11):1541-4. PubMed ID: 18276741
    [Abstract] [Full Text] [Related]

  • 9. The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy.
    Dujmovic I, Mangano K, Pekmezovic T, Quattrocchi C, Mesaros S, Stojsavljevic N, Nicoletti F, Drulovic J.
    J Neuroimmunol; 2009 Feb 15; 207(1-2):101-6. PubMed ID: 19162335
    [Abstract] [Full Text] [Related]

  • 10. Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males.
    Ovaskainen Y, Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M.
    Psychiatry Res; 2009 May 15; 167(1-2):73-9. PubMed ID: 19346005
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sleep disordered breathing in patients with primary Sjögren's syndrome: a group controlled study.
    Usmani ZA, Hlavac M, Rischmueller M, Heraganahally SS, Hilditch CJ, Lester S, Catcheside PG, Antic NA, Chai-Coetzer CL, McEvoy RD.
    Sleep Med; 2012 Sep 15; 13(8):1066-70. PubMed ID: 22841036
    [Abstract] [Full Text] [Related]

  • 13. Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study.
    Westhoff G, Dörner T, Zink A.
    Rheumatology (Oxford); 2012 Feb 15; 51(2):262-9. PubMed ID: 21705778
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism.
    Anaya JM, Correa PA, Herrera M, Eskdale J, Gallagher G.
    J Rheumatol; 2002 Sep 15; 29(9):1874-6. PubMed ID: 12233881
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis.
    Richette P, François M, Vicaut E, Fitting C, Bardin T, Corvol M, Savouret JF, Rannou F.
    J Rheumatol; 2008 Aug 15; 35(8):1650-4. PubMed ID: 18597398
    [Abstract] [Full Text] [Related]

  • 17. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool.
    Bowman SJ, Booth DA, Platts RG, UK Sjögren's Interest Group.
    Rheumatology (Oxford); 2004 Jun 15; 43(6):758-64. PubMed ID: 15039495
    [Abstract] [Full Text] [Related]

  • 18. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ, Yoo JJ, Yun CY, Kang EH, Lee HJ, Hyon JY, Song YW, Lee YJ.
    Rheumatology (Oxford); 2013 Dec 15; 52(12):2208-17. PubMed ID: 24023247
    [Abstract] [Full Text] [Related]

  • 19. Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome.
    Yamanaka G, Kawashima H, Oana S, Ishida Y, Miyajima T, Kashiwagi Y, Hoshika A.
    J Neurol Sci; 2010 Nov 15; 298(1-2):106-9. PubMed ID: 20807663
    [Abstract] [Full Text] [Related]

  • 20. Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome.
    Amin K, Lúdvíksdóttir D, Janson C, Nettelbladt O, Gudbjörnsson B, Valtysdóttir S, Björnsson E, Roomans GM, Boman G, Sevéus L, Venge P, BHR-Group. Bronchial hyper-responsiveness.
    Respir Med; 2001 Nov 15; 95(11):904-10. PubMed ID: 11716205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.